FindTrial
Sign In

Psychosexual health and quality of life under metformin in patients with polycystic ovary syndrome

Psychosexual health and quality of life under metformin in patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035982
Enrollment
59
Registered
2025-01-24
Start date
2021-04-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E28.2

Interventions

Group 1: PCOS patients with metformin Examinations at inclusion: transvaginal ultrasound to determine PCO morphology of the ovary, oral glucose tolerance test (oGTT/insulin). Examinations at each stud

Sponsors

Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: over 18, ESHRE criteria for PCOS met, capable of giving consent.

Exclusion criteria

Exclusion criteria: no desire to have children, no psychiatric illness or serious illness with an impact on PCOS

Design outcomes

Primary

MeasureTime frame
Improvements in Female Sexual Function Index, Hospital Anxiety and Depression Scale, Modified PCOS-Questionnaire—

Secondary

MeasureTime frame
improvements in metabolism—

Countries

Germany

Contacts

Public ContactKonstantin Hofmann

Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz

konstantin.hofmann@unimedizin-mainz.de06131 17 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026